FDA
-
-
-
-
-
-
-
Agomab Announces Design of NOV-ERA Phase 2b Study with Ontunisertib in Fibrostenosing Crohn’s Disease
-
-
334,496 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


